MindWalk Holdings Corp.

MindWalk Holdings Corp.

HYFT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$74.77M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MindWalk Holdings Corp.MindWalk Holdings Corp.-4.4--82%-0.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$74.77 Million
Enterprise Value$65.09 Million
Earnings per Share$-0.3
Beta0.78
Outstanding Shares46,807,089

Return

Return on Equity-81.55%ROE
Return on Assets-52.72%
Return on Invested Capital-68.91%

Valuation & Multiples

P/E Ratio-4.45P/E Ratio
PEG5.42PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue3.54
Enterprise Value to EBIT-5.22
Enterprise Value to Net Income-6
Total Debt to Enterprise0.07
Debt to Equity0.3Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 14, 2026
EPS Estimate
$-0.05
Consensus analyst estimate
Revenue Estimate
$3.22 M
Consensus analyst estimate

Next Earnings Call

Expected Date
December 21, 2026
EPS Estimate
$-0.05
Consensus analyst estimate
Revenue Estimate
$3.06 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-▼ 100.00%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %9.34%▼ 0.40%
Total Invested$6.90M▲ 35.00%
Investors Holding27▼ 1.00%

About ImmunoPrecise Antibodies Ltd

2,021 employees
CEO: Jennifer Lynne Bath

IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The...